MII IG Kerndatensatz-Modul Molekulares Tumorboard
2026.0.0 - release
Unknown region code '276'
MII IG Kerndatensatz-Modul Molekulares Tumorboard, published by Medizininformatik-Initiative. This guide is not an authorized publication; it is the continuous build for version 2026.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/medizininformatik-initiative/kerndatensatzmodul-molekulares-tumorboard/ and changes regularly. See the Directory of published versions
Profiles: MII PR MTB Systemtherapie Medication Statement, https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.0
partOf: Procedure Zytostatische Chemotherapie, Immuntherapie und antiretrovirale Therapie
status: Completed
medication: MIRVETUXIMAB SORAVTANSINE
subject: Kim Musterperson (no stated gender), DoB: 1956-03-14
effective: 2023-08-29 --> 2023-08-29
note:
29.08.2023 Z4 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22
dosage
DoseAndRates
Dose[x] 6 mg/kg KG (Details: UCUM codemg/kg{KG} = 'mg/kg{KG}')